Cencora, Inc. (NYSE:COR) Receives $399.00 Consensus PT from Analysts

Cencora, Inc. (NYSE:COR) has earned a consensus recommendation of “Moderate Buy” from the fourteen brokerages that are covering the firm, MarketBeat reports. Two analysts have rated the stock with a hold rating and twelve have issued a buy rating on the company. The average 12 month price target among brokers that have issued a report on the stock in the last year is $403.1667.

A number of equities research analysts recently weighed in on the stock. Leerink Partners restated an “outperform” rating on shares of Cencora in a report on Tuesday. Bank of America decreased their price objective on Cencora from $380.00 to $360.00 and set a “neutral” rating for the company in a report on Monday, January 5th. JPMorgan Chase & Co. increased their price objective on Cencora from $417.00 to $419.00 and gave the stock an “overweight” rating in a research note on Tuesday, February 10th. Barclays raised their target price on Cencora from $400.00 to $425.00 and gave the company an “overweight” rating in a report on Friday, February 13th. Finally, Evercore reaffirmed an “outperform” rating on shares of Cencora in a research report on Tuesday.

Insider Activity

In other news, CEO Robert P. Mauch sold 5,096 shares of the company’s stock in a transaction on Tuesday, January 20th. The shares were sold at an average price of $354.73, for a total value of $1,807,704.08. Following the completion of the sale, the chief executive officer owned 66,726 shares in the company, valued at $23,669,713.98. This represents a 7.10% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. 0.38% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Kemnay Advisory Services Inc. bought a new position in shares of Cencora during the 4th quarter worth approximately $25,000. Oakworth Capital Inc. bought a new position in shares of Cencora in the fourth quarter valued at approximately $26,000. Elyxium Wealth LLC purchased a new stake in shares of Cencora during the fourth quarter valued at approximately $27,000. Archer Investment Corp increased its position in shares of Cencora by 134.3% during the fourth quarter. Archer Investment Corp now owns 82 shares of the company’s stock valued at $28,000 after acquiring an additional 47 shares during the last quarter. Finally, Motiv8 Investments LLC bought a new stake in Cencora during the fourth quarter worth $29,000. 97.52% of the stock is currently owned by hedge funds and other institutional investors.

Cencora Stock Performance

Shares of COR stock opened at $327.96 on Friday. The company has a current ratio of 0.92, a quick ratio of 0.51 and a debt-to-equity ratio of 3.62. The firm has a fifty day simple moving average of $354.93 and a two-hundred day simple moving average of $339.92. Cencora has a 12 month low of $265.59 and a 12 month high of $377.54. The firm has a market capitalization of $63.80 billion, a PE ratio of 39.42, a price-to-earnings-growth ratio of 1.52 and a beta of 0.68.

Cencora (NYSE:COR) last released its quarterly earnings data on Wednesday, February 4th. The company reported $4.08 earnings per share for the quarter, beating analysts’ consensus estimates of $4.04 by $0.04. The firm had revenue of $85.93 billion for the quarter, compared to analyst estimates of $86.12 billion. Cencora had a net margin of 0.50% and a return on equity of 176.54%. The business’s quarterly revenue was up 5.5% compared to the same quarter last year. During the same period last year, the firm earned $3.73 earnings per share. Analysts forecast that Cencora will post 15.37 EPS for the current fiscal year.

Cencora Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Monday, March 2nd. Shareholders of record on Friday, February 13th were issued a dividend of $0.60 per share. This represents a $2.40 dividend on an annualized basis and a yield of 0.7%. The ex-dividend date of this dividend was Friday, February 13th. Cencora’s payout ratio is currently 28.85%.

About Cencora

Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.

Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.